Log In
Print
BCIQ
Print
Print this Print this
 

Myocet, doxorubicin

Also known as: formerly Evacet, TLC D-99

  Manage Alerts
Collapse Summary General Information
Company Teva Pharmaceutical Industries Ltd.
DescriptionLiposomal doxorubicin
Molecular Target Topoisomerase II (TOP2)
Mechanism of ActionTopoisomerase II inhibitor
Latest Stage of DevelopmentMarketed
IndicationBreast cancer
Partner

Sopherion Therapeutics LLC
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today